Navigation Links
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Date:11/5/2011

  • A retrospective examination of real-world practice habits indicated that there is a disconnect between EU gout treatment guidelines and current practice patterns among rheumatologists and primary care physicians in the United States (U.S.). The analysis found that with the availability of oral conventional urate-lowering therapies (ULTs), 64 percent of rheumatologists' patients and 70 percent of primary care physicians' patients had uric acid levels greater than 6 mg/dL; an indicator that their gout was not adequately controlled. In addition, 37.5 percent of patients in rheumatology practices and 14.2 percent of patients in primary care practices had tophi. These data suggest that patients under the care of rheumatologists had higher disease burden than those under the care of primary care physicians.

  • Results from a survey of 620 gout patients in the U.S. and select EU countries, including France, Germany, Italy, Spain and the United Kingdom, showed that patients with higher uric acid levels also reported the presence of tophi and experienced an increased number of gout flares.  Patients with tophi endured a greater disease burden compared to those without the deposits, including: greater overall work productivity loss (40.2 percent vs. 21.2 percent), activity impairment (48.7 percent vs. 37.2 percent), and more physician visits (9.0 vs. 6.5) (p<0.05 for all). Further, gout flares also impacted patients' mental and physical well-being. Patients reported a greater deterioration in their quality of life in correlation with the number of gout flares they experienced, as well as work- and social-related impairment.

  • Information from a U.S. database analysis of 24,503 gout patients underscored the link between gout symptom severity and the physical and economic cost to the patient.  According to the analysis, patients with tophi who experienced greater than or equal to 3 gout flares during the study had significantly more ph
    '/>"/>

  • SOURCE Savient Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
    2. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
    3. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    4. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
    5. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
    6. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
    7. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
    8. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
    9. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
    10. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
    11. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... , May 4, 2015   Synthetic Biologics, ... therapeutics focused on protecting the microbiome, as well as ... has been appointed Chief Financial Officer, Treasurer and Secretary ... Ballantyne who will be leaving the Company in ... brings to Synthetic Biologics operational, financial and international biotech ...
    (Date:5/4/2015)... Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ), ... of proprietary compounded drug therapies, today reported that it ... Wednesday, May 13, 2015.  The company will host a ... on the same day to discuss its financial results ... and webcast will be open to all listeners and ...
    (Date:5/1/2015)... 1, 2015  An effective advisory board serves ... but informed guidance to pharmaceutical organizations on various ... it is important for leaders to structure their ... Research and consulting leader Best Practices, ... and medical device executives in identifying ways to ...
    Breaking Medicine Technology:Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3Imprimis Pharmaceuticals to Host its First Quarter 2015 Financial Report Conference Call and Webcast on May 13, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its First Quarter 2015 Financial Report Conference Call and Webcast on May 13, 2015 at 4:30 p.m. EDT 3New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2
    ... ZURICH, July 19, 2010 , - Nycomed,s Protonix(R) ... District of New Jersey has Upheld Jury, Findings, ... , , ... of the U.S. District,Court for the District of New Jersey has confirmed the ...
    ... WASHINGTON , July 16 For years, homecare equipment ... guidelines for documenting the medical necessity of power wheelchairs for beneficiaries. ... reversed, the target of excessive audits and it restricts access to ... their perspective.   , , ...
    Cached Medicine Technology:Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid 2Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid 3Physician Outraged by Medicare Power Wheelchair Documentation Policy 2Physician Outraged by Medicare Power Wheelchair Documentation Policy 3Physician Outraged by Medicare Power Wheelchair Documentation Policy 4
    (Date:5/4/2015)... CCL, a top-ranked, global provider of ... to other leadership development consultancies. “The CCL Partner ... successful practitioners, expanding our capacity to drive results for ... R. Ryan, CCL President and CEO. , As soon ... Network , it will schedule a one-on-one conference with ...
    (Date:5/4/2015)... Diego, CA (PRWEB) May 04, 2015 ... a ribbon cutting ceremony at their brand new, 13,700 ... this year. The new building will not only provide ... population, but will also offer community and educational events ... The new facility is located next door to their ...
    (Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Benjamin ... Georgia proudly offers the latest non-surgical double-chin eliminator. ... facial plastic surgeon in Atlanta to offer Kybella ... to be injected specifically under the chin, promising to ... , Before Kybella, patients who sought immediate solutions for ...
    (Date:5/4/2015)... Unlike some camps, the Nike Middle School Running Camps are focused ... educate first and train second, with a significant amount of time ... are building the knowledge base needed to have a long and ... Effort Based Training, Running Heroes, Running Vocabulary, and Why am I ... not a camp where kids come to run and train hard ...
    (Date:5/4/2015)... Dr. Richard Champagne, DMD, MAGD is pleased ... the America’s Best Dentist Award, given by the National ... top dentist is a reflection of his vast experience ... compassion for his patients. , Each year, the National ... their field. These nominees are dentists who have exceptionally ...
    Breaking Medicine News(10 mins):Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2
    ... a daily basis has been stepped up in China, the ... out breaks of the much dreaded Avian influenza or “bird ... north-west regions two weeks ago. China has accelerated efforts to ... monitoring stations. The public at large and officials have been ...
    ... with a family history of lung cancer may be at ... new study. // ,Jun-Ichi Nitadori and colleagues at ... they looked into the health of more than 102,000 Japanese ... study, reported the online edition of health magazine WebMD. ...
    ... Injecting gold into knees affected by osteoarthritis may ease pain and ... it does not help everyone with rheumatoid arthritis. ,Arthritis ... the joints of the body. It is the leading cause of ... arthritis, each of which has a different cause. ,Researchers ...
    ... to shift gears and use decaffeinated coffee to avoid caffeine ... recent research and data compiled by the University of Florida ... caffeine. ,This month's Journal of Analytical Toxicology. has ... ,coffee which is one of the most prominent sources of ...
    ... all Public Offices across Bangkok the capital city of ... a senior official from the Bangkok Metropolitan Administration. ... Thai News Agency that the initial reforms have been ... BMA’s headquarters where smoking has already been prohibited in ...
    ... new survey showed that the total spending on Medicaid has ... was a reflection of a better economy// that has held ... federal Medicare drug benefit, according to a new survey. ,Medicaid ... has shown a growth of 2.8 percent in fiscal 2006, ...
    Cached Medicine News:Health News:Decaffeinated Coffee... Not Really! 2Health News:Lowest Spending growth in US Medicaid 2
    Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
    Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle....
    Flat handle 9 mm wide, angulated 45....
    Straight shafts with pointed tips and 6 mm tying platform. Smooth handle with dull finish. Fine pointed tips....
    Medicine Products: